The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 19, 2024

Filed:

Oct. 21, 2021
Applicants:

Medimmune, Llc, Gaithersburg, MD (US);

Humabs Biomed SA, Bellinzona, CH;

Inventors:

Ebony Benjamin, Gaithersburg, MD (US);

Nicole Kallewaard-LeLay, Gaithersburg, MD (US);

Josephine Mary McAuliffe, Gaithersburg, MD (US);

Frances Palmer-Hill, Gaithersburg, MD (US);

Leslie Wachter, Gaithersburg, MD (US);

Andy Yuan, Gaithersburg, MD (US);

Qing Zhu, Gaithersburg, MD (US);

Davide Corti, Bellinzona, CH;

Antonio Lanzavecchia, Bellinzona, CH;

Barbara Guarino, Bellinzona, CH;

Anna DeMarco, Bellinzona, CH;

Assignees:

MEDIMMUNE, LLC, Gaithersburg, MD (US);

HUMABS BIOMED SA, Bellinzona, CH;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/13 (2006.01); A61K 31/215 (2006.01); A61K 31/7012 (2006.01); A61K 39/395 (2006.01); A61K 39/42 (2006.01); A61K 45/06 (2006.01); C07K 16/10 (2006.01); C12P 21/00 (2006.01); G01N 33/569 (2006.01); G01N 33/577 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/1018 (2013.01); A61K 31/13 (2013.01); A61K 31/215 (2013.01); A61K 31/7012 (2013.01); A61K 39/3955 (2013.01); A61K 39/42 (2013.01); A61K 45/06 (2013.01); C12P 21/005 (2013.01); G01N 33/56983 (2013.01); G01N 33/577 (2013.01); A61K 2039/505 (2013.01); C07K 2317/24 (2013.01); C07K 2317/31 (2013.01); C07K 2317/33 (2013.01); C07K 2317/34 (2013.01); C07K 2317/54 (2013.01); C07K 2317/55 (2013.01); C07K 2317/565 (2013.01); C07K 2317/569 (2013.01); C07K 2317/622 (2013.01); C07K 2317/624 (2013.01); C07K 2317/626 (2013.01); C07K 2317/732 (2013.01); C07K 2317/734 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01); G01N 2333/11 (2013.01);
Abstract

The invention relates to antibodies and binding fragments thereof that are capable of binding to influenza A virus hemagglutinin and neutralizing at least one group 1 subtype and at least 1 group 2 subtype of influenza A virus.


Find Patent Forward Citations

Loading…